Fig. 1From: Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarctionReceiver operating curves for the predicted probabilities of selected risk scores before (blue line) and after (red line) the addition of four biomarkers to the conventional TIMI risk score. †The added biomarkers included hypoxic liver injury, dysglycemia, anemia and high neutrophil to lymphocyte ratioBack to article page